Liver steatosis, chronic kidney disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Selection criteria for patients with hepatic steatosis: Liver steatosis was diagnosed according to clinical diagnostic criteria (diagnosis was completed by 1-2 clinically experienced attending physicians), with complete steatosis test results and liver function test results, aged 18-75 years; 2. Selection criteria for patients with chronic kidney disease (CKD): According to clinical diagnostic criteria, chronic kidney disease (diagnosed by 1-2 physicians with clinical experience), GFR (glomerular filtration rate) test results and complete renal function test results, age 18-75 years.
Exclusion criteria
Exclusion criteria: 1. The exclusion criteria for patients with hepatic steatosis were viral hepatitis, drug-induced liver disease, Wilson's disease, total parenteral nutrition and autoimmune liver disease. Severe underlying diseases (heart, kidney, brain, etc.); 2. Exclusion criteria for patients with chronic kidney disease (CKD): patients with various acute kidney diseases, including renal tuberculosis, renal mass, renal vascular disease, patients after kidney transplantation, patients with congenital solitary kidney, unilateral renal dysplasia or severe ascites, patients with hydronephrosis, multiple calculi in kidney or medullary sponge kidney, juvenile, non-adult Individuals with complete behavioral ability, no serious underlying diseases (heart, brain, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shear wave dispersion; | — |
Secondary
| Measure | Time frame |
|---|---|
| Kidney size; | — |
Countries
China
Contacts
Peking University People's Hospital